Antonio Russo

Antonio Russo is a Full Professor of Precision Medicine at the University of Palermo, affiliated with the School of Medicine and Surgery and the Department of Medical Oncology. His research focuses on genetic mutations (e.g., BRCA), liquid biopsy, and biomarkers in oncology, particularly in ovarian, pancreatic, lung, and breast cancers. He leads studies on tumor immunology, therapeutic efficacy, and precision medicine strategies. He actively contributes to clinical trials, including those evaluating immunotherapy, targeted therapies, and novel biomarker applications. His administrative roles include managing relations with biomedical societies and patient associations.

Research interests span molecular profiling of cancers, resistance mechanisms to therapies, and the role of circulating tumor DNA (ctDNA) in diagnosis. Notable areas include the prognostic value of tumor-infiltrating lymphocytes, cardiotoxicity of targeted drugs, and the clinical utility of exosomes. His work integrates translational research with clinical practice, emphasizing personalized treatment approaches.

Publications highlight advancements in liquid biopsy, EGFR mutation detection, and PARP inhibitor efficacy. He collaborates on meta-analyses to optimize treatment protocols and address unmet clinical needs in metastatic cancers. His contributions aim to improve patient outcomes through innovative diagnostic and therapeutic strategies.